5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Diagnosis and Treatment of Carbon Monoxide Poisoning

      review-article
      , Dr. med. 1 , * , , Dr. med. 1 , , Prof. Dr. med. 2
      Deutsches Ärzteblatt International
      Deutscher Arzte Verlag

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The symptoms of carbon monoxide (CO) poisoning are nonspecific, ranging from dizziness and headache to unconsciousness and death. A German national guideline on the diagnosis and treatment of this condition is lacking at present.

          Method

          This review is based on a selective literature search in the PubMed and Cochrane databases, as well as on existing guidelines from abroad and expert recommendations on diagnosis and treatment.

          Results

          The initiation of 100% oxygen breathing as early as possible is the most important treatment for carbon monoxide poisoning. In case of CO poisoning, the reduced oxygen-carrying capacity of the blood, impairment of the cellular respiratory chain, and immune-modulating processes can lead to tissue injury in the myocardium and brain even after lowering of the carboxyhemoglobin (COHb) concentration. In patients with severe carbon monoxide poisoning, an ECG should be obtained and biomarkers for cardiac ischemia should be measured. Hyperbaric oxygen therapy (HBOT) should be critically considered and initiated within six hours in patients with neurologic deficits, unconsciousness, cardiac ischemia, pregnancy, and/or a very high COHb concentration. At present, there is no general recommendation for HBOT, in view of the heterogeneous state of the evidence from multiple trials. Therapeutic decision-making is directed toward the avoidance of sequelae such as cognitive dysfunction and cardiac complications, and the reduction of mortality. Smoke intoxication must be considered in the differential diagnosis. The state of the evidence on the diagnosis and treatment of this condition is not entirely clear. Alternative or supplementary pharmacological treatments now exist only on an experimental basis.

          Conclusion

          High-quality, prospective, randomized trials that would enable a definitive judgment of the efficacy of HBOT are currently lacking.

          Related collections

          Author and article information

          Journal
          Dtsch Arztebl Int
          Dtsch Arztebl Int
          Deutscher Arzte Verlag
          Deutsches Ärzteblatt International
          Deutscher Arzte Verlag
          1866-0452
          December 2018
          24 December 2018
          : 115
          : 51-52
          : 863-870
          Affiliations
          [1 ]Department of Anaesthesiology and Intensive Care University Hospital Bonn (UKB), Bonn
          [2 ]Clinic for Anesthesiology and Intensive Care Medicine, Hannover Medical School
          Author notes
          *Universitätsklinikum Bonn Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin Sigmund-Freud-Straße 25, 53105 Bonn lars.eichhorn@ 123456ukbonn.de
          Article
          PMC6381775 PMC6381775 6381775
          10.3238/arztebl.2018.0863
          6381775
          30765023
          1f8d0fd8-8cea-4b4e-8aae-4fe178f15ed2
          History
          : 4 June 2018
          : 24 September 2018
          Categories
          Review Article

          Comments

          Comment on this article